Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 2/20 | 0.47 |
| ▸ | APP | P05067 | 7/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | MAT2A | P31153 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | INSR | P06213 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13992026 | 1.00 | RELA (0.47) | RELAAPPNFE2L2ACHEPTGS1 | |
| SCHEMBL30151497 | 1.00 | RELA (0.47) | RELAAPPNFE2L2ACHEPTGS1 | |
| SCHEMBL13992003 | 1.00 | RELA (0.47) | RELAAPPNFE2L2ACHEPTGS1 | |
| SCHEMBL4260913 | 1.00 | RELA (0.47) | RELAAPPNFE2L2ACHEPTGS1 | |
| SCHEMBL12148768 | 1.00 | RELA (0.47) | RELAAPPNFE2L2ACHEPTGS1 | |
| SCHEMBL4260910 | 1.00 | RELA (0.47) | RELAAPPNFE2L2ACHEPTGS1 | |
| SCHEMBL24041888 | 0.96 | NFE2L2 (0.47) | RELAAPPNFE2L2PTGS1ALOX5 | |
| SCHEMBL7717148 | 0.96 | RELA (0.48) | RELAAPPNFE2L2ACHEPTGS1 | |
| SCHEMBL10128949 | 0.96 | RELA (0.48) | RELAAPPNFE2L2ACHEPTGS1 | |
| SCHEMBL21168151 | 0.96 | NFE2L2 (0.47) | RELAAPPNFE2L2PTGS1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1496044-B1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | BANDO CHEMICAL IND (JP) | 2010-11-03 | — | — | EP | disclosed |
| US-7271291-B2 | 1,3,5-tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-18 | — | — | US | disclosed |
| US-7196224-B2 | 1,3,5-tris(arylamino)benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-27 | — | — | US | disclosed |
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-03 | — | — | US | disclosed |
| US-20050090692-A1 | Novel 1,3,5-tris(arylamino)benzene | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2005-04-28 | — | — | US | disclosed |
| EP-1496044-A1 | NOVEL 1,3,5-TRIS(ARYLAMINO)BENZENE | Bando Chemical Industries, Ltd. (JP) | 2005-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173216-A1 | Novel 1, 3, 5 tris (arylamino) benzenes | HSPA4L, HSPA1A, GAPVD1 | RELA 2141/4885APP 1938/4885NFE2L2 732/4885 |
| US-20050090692-A1 | Novel 1,3,5-tris(arylamino)benzene | AHR, MYB, NAP1L4 | RELA 1523/4885APP 1416/4885NFE2L2 283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.